美国医疗保险将礼来、辉瑞和艾伯维的药品列入下一次医疗保险价格谈判范围

路透中文
Jan 28
美国医疗保险将<a href="https://laohu8.com/S/LLY">礼来</a>、<a href="https://laohu8.com/S/PFE">辉瑞</a>和艾伯维的药品列入下一次医疗保险价格谈判范围

路透1月27日 - 美国医疗保险与医疗补助服务中心周二宣布,礼来LLY.N、辉瑞PFE.N和艾伯维ABBV.N等大型制药公司的一批新的品牌药物被列入医疗保险药品价格谈判计划的第三周期,其中包括医疗保险B部分报销的首批产品。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10